ARCHIVES

How Elite Institutions Were Affected By A Decade of Constricted Funding

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Study Tests Method For Biomarker Validation

July 24, 2009

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

April 3, 2009

Report Says Many Cancers Could Be Prevented

February 27, 2009

In Brief: UC Irvine Wins Grant For Trial Of One-Visit Cervical Cancer Screening, Treatment

November 6, 1998

Budget Cut Asked By Ford Would Hold Grant Funding To 20%

January 10, 1975

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

November 8, 2002